New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
16:02 EDTLCILannett reports Q1 EPS 10c, consensus 5c
Reports Q1 revenue $35.29M, consensus $33.76M.
News For LCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
13:21 EDTLCILannett receives FDA approval for Dorzolamide HCL with Timolol
Lannett announced that it has received approval from the U.S. FDA of its Abbreviated New Drug Application for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, the therapeutic equivalent to the reference listed drug, Cosopt Ophthalmic Solution, 2%/0.5%, of Oak Pharmaceuticals, Inc.. According to IMS, for the year ended October 2014 total sales of Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, at Average Wholesale Price were approximately $123M.
December 8, 2014
17:34 EDTLCILannett served with subpoena in federal probe related to generic industry
Subscribe for More Information
11:30 EDTLCILeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
December 5, 2014
07:54 EDTLCILannett names Michael Bogda as president, effective December 1
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use